Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells (JCI Insight, 2021)

(untitled) - Artibani, M; Masuda, K; Hu, Z; Rauher, PC; Mallett, G; Wietek, N; Morotti, M; Chong, K; KaramiNejadRanjbar, M; Zois, CE; Dhar, S; El-Sahhar, S; et al.